Shares of Dynatronics Co. (NASDAQ:DYNT) have received an average recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $2.58.
A number of analysts recently issued reports on DYNT shares. Zacks Investment Research upgraded Dynatronics from a “hold” rating to a “buy” rating and set a $0.75 price target for the company in a research report on Tuesday, November 26th. Maxim Group set a $3.00 target price on Dynatronics and gave the stock a “buy” rating in a research report on Thursday, September 26th. Finally, ValuEngine upgraded Dynatronics from a “sell” rating to a “hold” rating in a report on Tuesday.
An institutional investor recently raised its position in Dynatronics stock. Vanguard Group Inc. raised its stake in Dynatronics Co. (NASDAQ:DYNT) by 76.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,484 shares of the medical equipment provider’s stock after purchasing an additional 21,870 shares during the period. Vanguard Group Inc. owned 0.60% of Dynatronics worth $83,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 11.70% of the stock is owned by institutional investors.
DYNT remained flat at $$0.73 during midday trading on Wednesday. 10,482 shares of the company’s stock traded hands, compared to its average volume of 12,878. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $1.27. Dynatronics has a 1-year low of $0.65 and a 1-year high of $2.88. The company has a quick ratio of 0.59, a current ratio of 1.36 and a debt-to-equity ratio of 0.59. The firm has a market cap of $6.46 million, a price-to-earnings ratio of -3.48 and a beta of 0.02.
Dynatronics (NASDAQ:DYNT) last released its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. Dynatronics had a negative net margin of 1.84% and a negative return on equity of 12.16%. The company had revenue of $16.39 million for the quarter, compared to analysts’ expectations of $16.21 million. On average, analysts expect that Dynatronics will post -0.13 EPS for the current year.
Dynatronics Company Profile
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Read More: What does an outperform rating mean?
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.